Atlas Trials

Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

Clinical trial NCT03158311 · COMPLETED

Trial details

NCT number
NCT03158311
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2018-02-05
Primary completion
2019-07-12
Enrollment
1426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.